Immunogen reported $-61053000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
Amgen AMGN:US $ 2176M 324M
Astellas Pharma 4503:JP 32.63B 44.87B
AstraZeneca AZN:LN 2.2B 673M
Bluebird Bio BLUE:US $ -100761000 19.58M
Bristol Myers Squibb BMY:US $ 3197M 9M
Cerulean Pharma CERU:US $ -8400450 1.14M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Emergent Biosolutions EBS:US $ -72000000 78.4M
Exelixis EXEL:US $ 83.71M 463K
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Immunogen IMGN:US $ -61053000 38.2M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Macrogenics MGNX:US $ -41808000 24.83M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Novartis NVS:US 3.32B 176M
Pfizer PFE:US $ 12099M 2104M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Seattle Genetics SGEN:US $ -133111000 61K